Kawashima K - Search Results

1

Inhibitory Effect of a Human MicroRNA, miR-6133-5p, on the Fibrotic Activity of Hepatic Stellate Cells in Culture.

Hamada-Tsutsumi S, Onishi M, Matsuura K, Isogawa M, Kawashima K, Sato Y, Tanaka Y. Hamada-Tsutsumi S, et al. Among authors: kawashima k. Int J Mol Sci. 2020 Oct 1;21(19):7251. doi: 10.3390/ijms21197251. Int J Mol Sci. 2020. PMID: 33019495 Free PMC article.

2

[Clinical manifestations of HBV genotypes].

Kawashima K, Tanaka Y. Kawashima K, et al. Nihon Rinsho. 2015 Dec;73 Suppl 9:434-8. Nihon Rinsho. 2015. PMID: 26845973 Japanese. No abstract available.

3

An Association Between Core Mutations in Hepatitis B Virus Genotype F1b and Hepatocellular Carcinoma in Alaskan Native People.

Hayashi S, Khan A, Simons BC, Homan C, Matsui T, Ogawa K, Kawashima K, Murakami S, Takahashi S, Isogawa M, Ikeo K, Mizokami M, McMahon BJ, Tanaka Y. Hayashi S, et al. Among authors: kawashima k. Hepatology. 2019 Jan;69(1):19-33. doi: 10.1002/hep.30111. Epub 2018 Dec 10. Hepatology. 2019. PMID: 29893492

4

Intrahepatic Cross-Presentation and Hepatocellular Antigen Presentation Play Distinct Roles in the Induction of Hepatitis B Virus-Specific CD8⁺ T Cell Responses.

Murata Y, Kawashima K, Sheikh K, Tanaka Y, Isogawa M. Murata Y, et al. Among authors: kawashima k. J Virol. 2018 Oct 12;92(21):e00920-18. doi: 10.1128/JVI.00920-18. Print 2018 Nov 1. J Virol. 2018. PMID: 30089700 Free PMC article.

5

Type I Interferon Signaling Prevents Hepatitis B Virus-Specific T Cell Responses by Reducing Antigen Expression.

Kawashima K, Isogawa M, Hamada-Tsutsumi S, Baudi I, Saito S, Nakajima A, Tanaka Y. Kawashima K, et al. J Virol. 2018 Nov 12;92(23):e01099-18. doi: 10.1128/JVI.01099-18. Print 2018 Dec 1. J Virol. 2018. PMID: 30209178 Free PMC article.

6

The antiviral effects of human microRNA miR-302c-3p against hepatitis B virus infection.

Hamada-Tsutsumi S, Naito Y, Sato S, Takaoka A, Kawashima K, Isogawa M, Ochiya T, Tanaka Y. Hamada-Tsutsumi S, et al. Among authors: kawashima k. Aliment Pharmacol Ther. 2019 Apr;49(8):1060-1070. doi: 10.1111/apt.15197. Epub 2019 Mar 3. Aliment Pharmacol Ther. 2019. PMID: 30828831

7

Restoration of type I interferon signaling in intrahepatically primed CD8+ T cells promotes functional differentiation.

Kawashima K, Isogawa M, Onishi M, Baudi I, Saito S, Nakajima A, Fujita T, Tanaka Y. Kawashima K, et al. JCI Insight. 2021 Feb 8;6(3):e145761. doi: 10.1172/jci.insight.145761. JCI Insight. 2021. PMID: 33400688 Free PMC article.

8

Interferon signaling suppresses the unfolded protein response and induces cell death in hepatocytes accumulating hepatitis B surface antigen.

Baudi I, Isogawa M, Moalli F, Onishi M, Kawashima K, Ishida Y, Tateno C, Sato Y, Harashima H, Ito H, Ishikawa T, Wakita T, Iannacone M, Tanaka Y. Baudi I, et al. Among authors: kawashima k. PLoS Pathog. 2021 May 12;17(5):e1009228. doi: 10.1371/journal.ppat.1009228. eCollection 2021 May. PLoS Pathog. 2021. PMID: 33979382 Free PMC article.

9

Bile acid dysmetabolism in the gut-microbiota-liver axis under hepatitis C virus infection.

Inoue T, Funatsu Y, Ohnishi M, Isogawa M, Kawashima K, Tanaka M, Moriya K, Kawaratani H, Momoda R, Iio E, Nakagawa H, Suzuki Y, Matsuura K, Fujiwara K, Nakajima A, Yoshiji H, Nakayama J, Tanaka Y. Inoue T, et al. Among authors: kawashima k. Liver Int. 2022 Jan;42(1):124-134. doi: 10.1111/liv.15041. Epub 2021 Sep 5. Liver Int. 2022. PMID: 34411400

10

HBV-Specific CD8+ T-Cell Tolerance in the Liver.

Baudi I, Kawashima K, Isogawa M. Baudi I, et al. Among authors: kawashima k. Front Immunol. 2021 Aug 6;12:721975. doi: 10.3389/fimmu.2021.721975. eCollection 2021. Front Immunol. 2021. PMID: 34421926 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,364 results

Search Page